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ALS is associated with RNA processing impairments involving the RNA-binding protein TDP-43. Pioneering a
novel RNA beacon to illuminate RNA trafficking in neurons, Alami et al. (2014) discover a cytoplasmic function
for TDP-43, suggesting a new disease mechanism.Amyotrophic lateral sclerosis (ALS), also
known as Lou Gehrig’s disease, is a
devastating and universally fatal neurode-
generative disorder characterized by the
selective loss of motor neurons from the
spinal cord and cortex. In recent years,
there has been a seismic shift in under-
standing of the causes and mechanisms
of ALS, with RNA-binding proteins and
alterations in RNA metabolic processes
emerging as powerful contributors to
disease pathogenesis (Ling et al., 2013).
This shift has been fueled by the initial
discovery that the RNA-binding protein
TDP-43 is a major component of the
pathological inclusions found in the de-
generating motor neurons of ALS patients
(Neumann et al., 2006) and that muta-
tions in the gene encoding TDP-43 cause
some cases of familial and sporadic ALS
(Chen-Plotkin et al., 2010). The conjunc-
tion of genetics and pathology clearly
implicates TDP-43 as central to ALS
and now the race is on to unravel the
mechanisms by which it contributes to
disease. What is its normal function?
How do disease-associated mutations or
pathological mislocalization affect that
function? Since TDP-43 contributes
broadly to ALS (depleted from the nucleus
and mislocalized to cytoplasmic inclu-
sions in virtually all ALS cases), decipher-
ing TDP-43’s normal cellular role and
its role in disease could help to suggest
novel and broadly applicable therapeutic
strategies.
TDP-43 is a ubiquitously expressed
DNA- and RNA-binding protein, originally
identified as a transcriptional repressor
and splicing regulator. TDP-43 localizes
primarily to the nucleus but can also be
found in the cytoplasm, as it shuttles be-
tween the two compartments (Chen-Plot-
kin et al., 2010). In the cytoplasm, it has
been shown to associate with mRNPgranules, known as stress granules,
which are transient sites of translational
repression of mRNAs that form upon ex-
posure to diverse environmental stresses
(Li et al., 2013). ALS-linked mutations in
TDP-43 can impair stress granule dy-
namics (Liu-Yesucevitz et al., 2010) and
alterations in stress granule form and
function (e.g., assembly and disassembly)
per se may well be a major component
of ALS and related neurodegenerative
diseases (Li et al., 2013; Ramaswami
et al., 2013). However, stress granules
are not cell type specific and are pre-
sent in all cell types, including neurons.
Neurons also contain specialized types
of mRNP granules that transport specific
mRNA cargos from the cell body to axons
and dendrites. In highly polarized neu-
rons, with axons and dendrites that
often terminate long distances from the
soma, the transport of cellular supplies,
including mRNA, to distal locations is
incredibly important for normal cell
function and defects in this process can
lead to neuronal dysfunction. Given its
already described role in stress granules,
an intriguing question arises: could TDP-
43 function in other types of mRNP gran-
ules, such as neuronal RNA transport
granules, and could this role explain its
involvement in ALS pathogenesis and
motor neuron degeneration? TDP-43
had previously been shown to associate
with multiple proteins that are part of
mRNP granules (e.g., staufen, FMRP,
SMN, and HuD), including neuronal trans-
port granules (Freibaum et al., 2010).
TDP-43 has also been shown to bind to
the 30 UTRs of many target mRNAs,
further evidence for a role in regulating
the stability or transport of those mRNAs
(Tollervey et al., 2011). However, the
mechanisms by which TDP-43 regulates
the spatial distribution of target mRNAsNeuron 81and the impact of disease mutations
remain unresolved.
To define the role of TDP-43 in the cyto-
plasm, Alami et al. (2014) start out by using
transgenic Drosophila that they engi-
neered to express wild-type or mutant
TDP-43 in motor neurons. Consistent
with previous reports by others, they
found wild-type TDP-43 was mainly local-
ized to the nucleus. But they also found
TDP-43 present in cytoplasmic granules
that were distributed throughout the
axon, even to distal parts of the axon and
into the neuromuscular junction (NMJ).
Interestingly, two independent disease-
associated mutations impaired TDP-43’s
localization, preventing it from reaching
thedistal axons andNMJs.Because these
TDP-43 transgenes were fluorescently
labeled, they were next able to use in vivo
imaging of Drosophila motor neurons
to visualize TDP-43-containing granules
transported up and down axons. These
granuleswouldmovebidirectionally, often
for long distances, pause for a bit, and
then continue their journey. Compared to
wild-type, the ALS-linked mutant TDP-
43-containing granules were transported
less efficiently; their movements were
interrupted with more pauses, resulting
in more retrograde movement. This
impaired anterograde movement of the
mutant TDP-43 granules explains their
diminished ability to reach distal axons
and the NMJ.
Alami et al. (2014) next extend their
findings from Drosophila to primary
mouse cortical neurons. Again, using fluo-
rescently tagged wild-type and mutant
TDP-43, they visualized TDP-43 associ-
ating with cytoplasmic RNA transport
granules and trafficking down the axons
in a net anterograde direction. This pro-
cess was less efficient (more pauses and
direction reversals) with the TDP-43, February 5, 2014 ª2014 Elsevier Inc. 463
Figure 1. Multiple Potential Mechanisms by which TDP-43 Mutations Could Conspire to
Cause ALS
(A) In healthy neurons, wild-type TDP-43 localizes primarily to the nucleus and also to cytoplasmic mRNP
granules, including neuronal transport granules, where it promotes their anterograde movement.
(B) ALS-causing TDP-43 mutations (or pathological mislocalization of the wild-type protein) result in
several possible cellular defects. (1) Depletion of TDP-43 from the nucleus causes a loss of its nuclear
function, resulting in massive changes in gene expression at the level of transcription and alternative
splicing (e.g., Polymenidou et al., 2011). (2) Accumulation of TDP-43 aggregates in the cytoplasm can
have toxic gain-of-function effects (e.g., Johnson et al., 2009), perhaps by sequestering RNAs and
RNA-binding proteins. (3) Alami et al. (2014) propose a newmechanism in which TDP-43 mutations cause
a loss of cytoplasmic function by impairing its ability to promote the anterograde transport of mRNA-
containing cytoplasmic transport granules from the soma to distal parts of the axon.
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Previewsmutants. Alami et al. (2014) provide evi-
dence that this transport is microtubule
dependent (instead of actin dependent)
and, interestingly, does not seem to be
due to general defects in axonal transport
because microtubule-dependent trans-
port processes (e.g., mitochondria trans-
port) are unaffected by TDP-43 in their
system. Thus, the ability of TDP-43 to
associate with cytoplasmic transport
granules and traffic to distal parts of the
axon in a net anterograde direction is
conserved from flies to mice and dis-
ease-associated mutations cause a par-
tial loss of this function.
Alami et al. (2014) next devised a clever
strategy to visualize the actual mRNA
within the transport granules. Harnessing
a recent technological advancement
for mRNA detection in live cells, Alami
et al. (2014) engineered a fluorescent
‘‘mRNA beacon,’’ essentially a fluores-
cently labeled oligonucleotide, which hy-
bridizes to Neurofilament-L (Nefl) mRNA,
a known target of TDP-43 and a well-464 Neuron 81, February 5, 2014 ª2014 Elseestablished component of cytoplasmic
RNA granules. Using this reagent, they
visualizedNeflmRNA frequently localizing
to TDP-43-containing granules within
axons. But sometimes TDP-43 was
absent from theNefl-positivemRNP gran-
ules, allowing Alami et al. (2014) to
compare the movement of TDP-43-posi-
tive and -negative granules within the
same axon. Remarkably, even though
both types of granules contained Nefl
mRNA, the TDP-43-containing granules
exhibited predominantly anterograde
movement, whereas the ones without
TDP-43 moved in more of a retrograde
fashion. Thus, it seems that TDP-43
selectively associates with granules in-
volved in the anterograde transport of
mRNA cargos within axons. Because the
ALS-linked mutations affect this process,
TDP-43might also functionally participate
in this transport rather than simply being a
marker of the mRNP granules.
The final piece to the puzzle was for the
authors to validate their findings in humanvier Inc.patient-derived cells. Alami et al. (2014)
obtained induced pluripotent stem (iPS)
cells from ALS patients harboring three
different TDP-43 mutations (G298S,
A315T, and M337V) along with control
cells from healthy individuals. Using
established protocols, they differentiated
these cells into motor neurons and com-
pared the kinematics of mRNA granule
transport (using their novel mRNA ‘‘bea-
con’’ approach). Just like in the fly and
mouse experiments, neurons harboring
TDP-43 mutations exhibited impairments
in the anterograde transport of NEFL-
containing mRNP granules. These results
reveal a specific cellular phenotype asso-
ciated with TDP-43 mutation and suggest
that, at least in part, one mechanism by
which TDP-43 mutations can cause ALS
is by loss of its cytoplasmic function.
Additional gain-of-function and loss of
nuclear function effects have been pro-
posed and perhaps all contribute to dis-
ease to some extent (Figure 1).
Using three diverse model systems (fly,
mouse primary neurons, and neurons
derived from human ALS patient iPS
cells), Alami et al. (2014) have discovered
an unexpected and powerful requirement
for TDP-43 in the transport of RNA gran-
ules. They also develop a novel technique
to visualize transport of specific TDP-43
mRNA cargos up and down axons in living
neurons. Although it has been noted
previously that TDP-43 can localize to
the cytoplasm and interact with RNA-
binding proteins involved in mRNP
granule transport, the direct role, if
any, for TDP-43 in the cytoplasm has
remained enigmatic. Alami et al. (2014)
have overcome this problem by discov-
ering that TDP-43 functions in the cyto-
plasm to selectively transport mRNP
granules in an anterograde manner and
showing how impairments in this function
might contribute to neurodegeneration.
RNA granules—assemblies of RNAs and
RNA-binding proteins—are emerging as
key regulators of diverse RNA metabolic
processes. Thus, dysfunction in RNA
granule assembly or dynamics may be
sufficient to cause neurodegeneration. If
so, therapeutic strategies aimed at modu-
lating RNA granule assembly, dynamics,
or disassembly may be efficacious for
ALS and related neurodegenerative dis-
eases (Kim et al., 2013; Li et al., 2013;
Ramaswami et al., 2013).
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In this issue of Neuron, Han et al. (2014) develop powerful methods to visualize phagocytosis of Drosophila
peripheral sensory neuron dendrites. Remarkably, epidermal cells rather than professional phagocytes are
the primary mediators of debris clearance, using both familiar and new molecular players.In theDrosophila larval peripheral nervous
system (PNS), there are some gorgeous
sensory neurons that tile along the barrier
epidermis. The development and arbori-
zation of these cells has been intensively
studied by a number of groups (Jan and
Jan, 2010). During metamorphosis (Wil-
liams and Truman, 2005) or after injury
(Sugimura et al., 2003), their peripheral
processes degenerate and are rapidly
cleared prior to remodeling or regen-
eration. Previous studies showed that
Drosophila plasmatocytes, a macro-
phage-like circulating blood cell, can be
found at sites of injury or programmed
remodeling and can contain dendritic
cell material during the clearance process
(Williams and Truman, 2005). This obser-
vation was consistent with the view
that in organisms that possess them,circulating macrophage-like cells are the
undisputed champions at clearing cell
debris. The question that opens the Han
et al. (2014) study is a simple sufficiency
experiment—are plasmatocytes neces-
sary for dendritic clearance during meta-
morphosis or after injury? The answer
to this question was a surprising no.
Although plasmatocyte ablation slightly
delayed dendrite fragmentation after
injury, ultimately degenerating cells were
cleared. This begged the question, if not
plasmatocytes, then who?
‘‘Nonprofessional’’ Phagocytosis, a
Job for Neighboring Cells?
There are at least two prominent exam-
ples in which macrophages are not the
primary phagocyte. The first is in organ-
isms like C. elegans, which lack circu-lating macrophage-like cells entirely.
Such organisms must rely on other
cell types to clear both apoptotic and
injury-induced cell debris. Indeed, in
C. elegans, apoptotic cells of the larval
ventral nerve cord are engulfed by local
hypodermal cells during development
and it has also been speculated that den-
dritic debris after axonal injury may also
be cleared by these same cells (Chisholm
and Xu, 2012). The second example is in
the vertebrate CNSwhere the blood-brain
barrier prevents macrophages from gain-
ing access. Here, microglia derived from
the same monocyte lineage as macro-
phages act as the primary phagocytes,
displaying macrophage-like filopodia
that draw in and engulf cellular debris
(Neumann et al., 2009). Additionally, in
certain areas of the brain where microglia, February 5, 2014 ª2014 Elsevier Inc. 465
